Clonal hematopoiesis: mechanisms driving dominance of stem cell clones

Grant A. Challen, Margaret A. Goodell

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations


The discovery of clonal hematopoiesis (CH) in older individuals has changed the way hematologists and stem cell biologists view aging. Somatic mutations accumulate in stem cells over time. While most mutations have no impact, some result in subtle functional differences that ultimately manifest in distinct stem cell behaviors. With a large pool of stem cells and many decades to compete, some of these differences confer advantages under specific contexts. Approximately 20 genes are recurrently found as mutated in CH, indicating they confer some advantage. The impact of these mutations has begun to be analyzed at a molecular level by modeling in cell lines and in mice. Mutations in epigenetic regulators such as DNMT3A and TET2 confer an advantage by enhancing self-renewal of stem and progenitor cells and inhibiting their differentiation. Mutations in other genes involved in the DNA damage response may simply enhance cell survival. Here, we review proposed mechanisms that lead to CH, specifically in the context of stem cell biology, based on our current understanding of the function of some of the CH-associated genes.

Original languageEnglish
Pages (from-to)1590-1598
Number of pages9
Issue number14
StatePublished - Oct 1 2020


Dive into the research topics of 'Clonal hematopoiesis: mechanisms driving dominance of stem cell clones'. Together they form a unique fingerprint.

Cite this